Shanghai Pharmaceuticals Holding Co. Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 105,237.000 million compared to CNY 87,165.105 million a year ago. Operating income was CNY 5,230.127 million compared to CNY 3,633.508 million a year ago. Net income was CNY 3,567.759 million compared to CNY 2,442.842 million a year ago. Basic earnings per share from continuing operations was CNY 1.26 compared to CNY 0.86 a year ago.